MedBiome is a biopharmaceutical company based in Canada, founded in 2018. The company's slogan, "Targeting the microbiome to improve human health," reflects its focus on developing novel approaches to inflammatory bowel disease (IBD), Alzheimer's Disease, and colorectal cancer management by leveraging its platform for identification, screening, and development of microbiome modulators. Through patient stratification and the development of microbiome-targeted therapeutic and nutritional approaches, MedBiome aims to make significant strides in the treatment of these conditions. Currently, there is no disclosed information about the last investment and investors in the company.
MedBiome
Targeting the microbiome to improve human health
Founded 2018
Ottawa, Canada
1 employees
Biotechnology, Pharmaceutical
Ottawa, Canada
1 employees
Biotechnology, Pharmaceutical
General Information
Company Name
MedBiome
Founded Year
2018
Location
Ottawa, Canada
Ottawa, Canada
Employees
1
Industries
Biotechnology, Pharmaceutical
BounceWatch is an independent company data service, not affiliated with MedBiome. To contact MedBiome, visit medbiome.ca.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does MedBiome compare?
A PDF of MedBiome and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting MedBiome soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Canada Market
Biotechnology
About MedBiome
Business keywords: biopharmaceutical, microbiome modulators, inflammatory bowel disease, Alzheimer's Disease, colorectal cancer, therapeutic approaches, nutritional approaches, compound libraries, bioinformatics, metagenomics, metabolomics, drug development
No funding data available for MedBiome yet.
MedBiome Alternatives & Competitors
View All Alternatives
MedBiome vs
Pioneering the future of gut health with novel microbiome modulators for impactful patient outcomes.
Post-IPO Equity
Biotechnology, Health Care
MedBiome vs
Prisys Biotechnologies
China
Better Human Health by Primate Translational Sciences.
30 employees
Biotechnology, Pharmaceutical
MedBiome vs
Laminar Pharma
Spain
Biopharmaceutical company performing discovery, rational design and initial clinical development of...
39 employees
Biotechnology, Life Sciences
FAQ About MedBiome
Targeting the microbiome to improve human health
MedBiome was founded in 2018.
MedBiome is headquartered in Ottawa, Canada.
MedBiome operates in Biotechnology and Pharmaceutical. Its work centres on biopharmaceutical, microbiome modulators, inflammatory bowel disease and Alzheimer's Disease.
MedBiome has approximately 1 employees.
Top alternatives and competitors to MedBiome include Ritter Pharmaceuticals, Prisys Biotechnologies, Laminar Pharma, MTHERA PHARMA, RH Nanopharmaceuticals . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MedBiome and Ritter Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for MedBiome, https://bouncewatch.com/company/medbiome, updated 2 January 2025. When citing, please name BounceWatch and link this page.
